Skip to content

Nuo Therapeutics, Inc.: 10-Q filed 2011-08-15

What Nuo Therapeutics, Inc. reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 36 published measures, 92 facts as tagged in accession 0001144204-11-047310.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-15
Fiscal period
fiscal Q2 2011
Accession
0001144204-11-047310 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Nuo Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-307,964,425USD
At 2010-12-318,900,364USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-305,453,763USD
At 2010-12-318,979,616USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-302,510,662USD
At 2010-12-31-79,252USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-791,361USD91
2011-01-01 to 2011-06-30-2,201,581USD181
2010-04-01 to 2010-06-30-2,257,359USD91
2010-01-01 to 2010-06-30-3,325,325USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-2,654,889USD181
2010-01-01 to 2010-06-30-2,384,198USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,561USD181
2010-01-01 to 2010-06-3076,413USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,394,294USD91
2011-01-01 to 2011-06-302,759,907USD181
2010-04-01 to 2010-06-301,147,219USD91
2010-01-01 to 2010-06-301,325,953USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-302,272,729USD181
2010-01-01 to 2010-06-303,392,828USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-3045,015USD181
2010-01-01 to 2010-06-30-2,046,518USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-49,873,224USD
At 2010-12-31-47,671,643USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-04-01 to 2011-06-305,000USD91
2011-01-01 to 2011-06-3010,000USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-301,114,067USD
At 2010-12-311,324,996USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-30138,955USD181
2010-01-01 to 2010-06-30180,771USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,237,978USD91
2011-01-01 to 2011-06-30-2,720,705USD181
2010-04-01 to 2010-06-30-1,559,832USD91
2010-01-01 to 2010-06-30-2,620,538USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-302,708,640USD
At 2010-12-313,494,517USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-303,329,763USD
At 2010-12-315,171,961USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-06-30706,823USD
At 2010-12-31706,823USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-06-301,224,423USD
At 2010-12-311,207,027USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,993,045USD91
2011-01-01 to 2011-06-304,196,001USD181
2010-04-01 to 2010-06-302,021,773USD91
2010-01-01 to 2010-06-303,435,656USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-30401,912USD
At 2010-12-31627,984USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30755,067USD91
2011-01-01 to 2011-06-301,475,296USD181
2010-04-01 to 2010-06-30461,941USD91
2010-01-01 to 2010-06-30815,118USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2011-04-01 to 2011-06-30639,227USD91
2011-01-01 to 2011-06-301,284,611USD181
2010-04-01 to 2010-06-30685,278USD91
2010-01-01 to 2010-06-30510,835USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-3042,107USD91
2011-01-01 to 2011-06-30102,053USD181
2010-04-01 to 2010-06-30156,407USD91
2010-01-01 to 2010-06-30220,898USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3051,954,810shares
At 2010-12-3144,103,743shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-06-3052,378,674USD
At 2010-12-3147,587,964USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-06-303,049,458USD
At 2010-12-313,182,875USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-30591,306USD
At 2010-12-31610,409USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-878,004USD91
2011-01-01 to 2011-06-30-2,374,794USD181
2010-04-01 to 2010-06-30-4,292,247USD91
2010-01-01 to 2010-06-30-5,363,629USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30705,547USD91
2011-01-01 to 2011-06-301,549,091USD181
2010-04-01 to 2010-06-30679,494USD91
2010-01-01 to 2010-06-301,145,181USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-01-01 to 2011-06-30318,911USD181
2010-01-01 to 2010-06-30142,677USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-3,348USD91
2011-01-01 to 2011-06-30-53,585USD181
2010-04-01 to 2010-06-30-3,143USD91
2010-01-01 to 2010-06-30-7,846USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30451,617USD91
2011-01-01 to 2011-06-30529,124USD181
2010-04-01 to 2010-06-30-697,527USD91
2010-01-01 to 2010-06-30-704,787USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2011-01-01 to 2011-06-3010,000USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-302,814,235USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30695,020USD181
2010-01-01 to 2010-06-30877,133USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-226,072USD181
2010-01-01 to 2010-06-30-146,649USD181

Inspect the source

Entity
Nuo Therapeutics, Inc. / CIK 0001091596
Captured
2026-09-20T05:21:57.848Z
SEC response SHA-256
f9d1094a0912aec87dd50c0e6f3c9b7f90d3de5f7435cbf00ae5d71aa22d4723

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001091596.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))